Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD
0.0130
0.00 (0.00%)
Mar 3, 2026, 3:48 PM AEST
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Developing and Commercialising Pharmaceutical Products | 1.19M | 5.09M | 8.43M | 1.72M | 1.34M | | | | | |
Developing and Commercialising Pharmaceutical Products Growth | -76.63% | -39.60% | 390.34% | 28.57% | 6.70% | | | | | |
| 1.19M | 5.09M | 8.43M | 1.72M | 1.34M | | | | | |
| -76.63% | -39.60% | 390.34% | 28.57% | 6.70% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| 3.34M | 3.01M | 3.50M | 3.38M | 3.82M | | | | | |
| 11.04% | -14.09% | 3.43% | -11.42% | 44.39% | | | | | |
| 1.19M | 4.47M | 1.14M | 299.00K | 312.00K | | | | | |
United States of America Growth | -73.38% | 291.08% | 282.27% | -4.17% | -27.78% | | | | | |
Europe and Other Countries | - | 622.00K | 7.29M | 1.42M | 1.03M | | | | | |
Europe and Other Countries Growth | - | -91.46% | 412.74% | 38.63% | 18.09% | | | | | |
| 4.53M | 8.10M | 11.93M | 5.10M | 5.16M | | | | | |
| -44.08% | -32.11% | 133.74% | -1.03% | 30.70% | | | | | |
Source: S&P Global Market Intelligence.
